CDC recently revised its lead screening recommendations in a guidance document published in November 1997. The revised recommendations are aimed at improving the prevention-effectiveness of lead screening, by calling on state and local health officials to develop statewide plans for lead screening and follow-up care, tailoring approaches to local conditions, including declining local BLL prevalence, including advisory committees with diverse representation to review data and develop a statewide screening plan. This project was to: 1) monitor the process of plan development, 2) identify states that are well along in development of plans, 3) study the process used by these states to develop a statewide plan, both in terms of key implementation steps and costs of developing the plans, and 4) disseminate the information from these case studies to other jurisdictions to help them develop their plans. Data collection for the study included reviews of applications and site visits to profile the efforts of five selected "early adopter: sites. The study resulted in several findings for states implementing this new process including recommendations on committee membership, committee structure, effective use of data, gainig provider participation in and acceptance of the new guidelines, and ways to ensure that committee recommendations are implemented.
Learning Objectives: By the end of this presentation, participants will (1) understand CDC's new guidelines for screening young children, (2) understand the history and rationale for the advisory committee and state plan approach, (3) be familiar with the evaluation challenges in determining impact of guidelines, and (4) be familiar with ways in which 5 sites have effectively developed advisory committees and targeted, customized screening recommendations
Keywords: Lead, Evaluation
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.